Braze (BRZE) just posted its Q3 2026 numbers with investors zeroing in on how its recent top line near $180 million and ongoing negative EPS compare with the company’s still sizeably negative net income profile. The company has seen quarterly revenue move from about $135 million in Q1 2025 to roughly $180 million by Q2 2026, while basic EPS has stayed in the red, ranging between about -$0.17 and -$0.35 over that stretch. This underscores how growth is still bumping up against stubborn losses. With revenue traction set against widening past losses, the focus this quarter is on whether Braze can eventually turn those expanding customer dollars into healthier margins rather than just bigger deficits.
See our full analysis for Braze.With the latest numbers on the table, the next step is to see how this mix of solid top line momentum and fragile margins lines up with the prevailing growth narrative and the more cautious profit outlook that many investors already have in mind.
See what the community is saying about Braze
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Braze on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
See the numbers from another angle, and in just a few minutes turn that take into your own data driven story: Do it your way.
A great starting point for your Braze research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
Braze is still wrestling with sizeable losses, a questionable valuation versus its DCF estimate, and notable insider selling despite strong revenue momentum.
If you want ideas where price better reflects fundamentals and insiders are signaling confidence instead of cashing out fast, use these 905 undervalued stocks based on cash flows to look for candidates with potentially more compelling upside and fewer valuation red flags.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com